376 related articles for article (PubMed ID: 32167254)
1. [Not Available].
Nau JY
Rev Med Suisse; 2020 Mar; 16(685):510-511. PubMed ID: 32167254
[No Abstract] [Full Text] [Related]
2. Of chloroquine and COVID-19.
Touret F; de Lamballerie X
Antiviral Res; 2020 May; 177():104762. PubMed ID: 32147496
[TBL] [Abstract][Full Text] [Related]
3. Chloroquine and COVID-19, where do we stand?
Lecuit M
Med Mal Infect; 2020 May; 50(3):229-230. PubMed ID: 32217166
[No Abstract] [Full Text] [Related]
4. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
Malviya A
Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
[No Abstract] [Full Text] [Related]
5. COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
Marmor MF
Am J Ophthalmol; 2020 Aug; 216():A1-A2. PubMed ID: 32439074
[No Abstract] [Full Text] [Related]
6. COVID-19: Stay Cool toward Corticosteroids.
Fujishima S
Keio J Med; 2020 Jun; 69(2):27-29. PubMed ID: 32475851
[No Abstract] [Full Text] [Related]
7. Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.
Ayaz S; Crea F
Epigenomics; 2020 May; 12(10):811-812. PubMed ID: 32495654
[No Abstract] [Full Text] [Related]
8. [Chloroquine as a possible treatment for COVID-19].
Coumou J; de Vries PJ
Ned Tijdschr Geneeskd; 2020 Mar; 164():. PubMed ID: 32391999
[TBL] [Abstract][Full Text] [Related]
9. Novel Coronavirus (SARS-CoV-2) resistance in African populations: A cause worth exploring.
Krishan K; Kanchan T
Acta Biomed; 2020 Sep; 91(3):e2020023. PubMed ID: 32921745
[TBL] [Abstract][Full Text] [Related]
10. Uncertainty about the Efficacy of Remdesivir on COVID-19.
Yoo JH
J Korean Med Sci; 2020 Jun; 35(23):e221. PubMed ID: 32537956
[No Abstract] [Full Text] [Related]
11. Importance of Environmental Factors on Production of Computationally- Defined Natural Molecules against COVID-19 Pandemic.
Abouleish M; El-Keblawy A; Mosa KA; Soliman SSM
Curr Top Med Chem; 2020; 20(22):1958-1961. PubMed ID: 33040729
[No Abstract] [Full Text] [Related]
12. COVID-19: Small-Molecule Clinical Trials Landscape.
Ferreira LLG; Andricopulo AD
Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
[No Abstract] [Full Text] [Related]
13. Science in the Wake of the Pandemic: How Will COVID-19 Change the Way We Do Research?
Mol Cell; 2020 Jul; 79(1):9-10. PubMed ID: 32619472
[No Abstract] [Full Text] [Related]
14. Statins in coronavirus outbreak: It's time for experimental and clinical studies.
Bifulco M; Gazzerro P
Pharmacol Res; 2020 Jun; 156():104803. PubMed ID: 32289478
[No Abstract] [Full Text] [Related]
15. Chloroquine for COVID-19: rationale, facts, hopes.
Cortegiani A; Ippolito M; Ingoglia G; Einav S
Crit Care; 2020 May; 24(1):210. PubMed ID: 32384908
[No Abstract] [Full Text] [Related]
16. Lithium for the 2019 novel coronavirus.
Gómez-Bernal G
Med Hypotheses; 2020 Sep; 142():109822. PubMed ID: 32408073
[No Abstract] [Full Text] [Related]
17. [SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].
Ladoux A; Azoulay S; Dani C
Med Sci (Paris); 2020; 36(6-7):555-558. PubMed ID: 32558640
[No Abstract] [Full Text] [Related]
18. Chloroquine or Hydroxychloroquine for COVID-19: Is Cardiotoxicity a Concern?
Kamp TJ; Hamdan MH; January CT
J Am Heart Assoc; 2020 Jun; 9(12):e016887. PubMed ID: 32463308
[No Abstract] [Full Text] [Related]
19. Is the type of diabetes treatment relevant to outcome of COVID-19?
Bloomgarden Z
J Diabetes; 2020 Jul; 12(7):486-487. PubMed ID: 32353193
[No Abstract] [Full Text] [Related]
20. Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach.
Sarma P; Prajapat M; Avti P; Kaur H; Kumar S; Medhi B
Indian J Pharmacol; 2020; 52(1):1-5. PubMed ID: 32201439
[No Abstract] [Full Text] [Related]
[Next] [New Search]